Navigation

Published technology appraisals

This table lists published NICE technology appraisals. The list can be sorted by title (alphabetically), issue date and review date. You can also:

  • click the appraisal title for full details
  • click a column heading to sort the list by that column

Please note that the 'review date' is not the date when a review of it the appraisal starts, but the date NICE consults on a proposal for reviewing it. There is no guarantee that at the review date, a review will be undertaken. Appraisals which have been considered for review and where the decision has been not to carry out a review at this time are listed in static technology appraisals.

More information on the published appraisals list.

For technology appraisal guidance organised by category, use Find guidance in the main header area above.

Searching for specific technology appraisal guidance?

Published appraisals

Results 121-140 of 308

Ref Title Date Issued Review
TA162 Lung cancer (non-small-cell) - erlotinib (TA162) Nov 2008 Jun 2010
TA127 Multiple sclerosis - natalizumab (TA127) Aug 2007 TBC
TA120 Heart failure - cardiac resynchronisation (TA120) May 2007 TBC
TA141 Rheumatoid arthritis (refractory) - abatacept (TA141) (replaced by TA195) Apr 2008 Jul 2010
TA126 Rheumatoid arthritis (refractory) - rituximab (TA126) (replaced by TA195) Aug 2007 Jul 2010
TA160 Osteoporosis - primary prevention (TA160) Jan 2011 Jul 2010
TA161 Osteoporosis - secondary prevention including strontium ranelate (TA161) Jan 2011 TBC
TA121 Glioma (newly diagnosed and high grade) - carmustine implants and temozolomide (TA121) Jun 2007 TBC
TA128 Haemorrhoid - stapled haemorroidopexy (TA128) Sep 2007 TBC
TA165 Organ preservation (renal) - machine perfusion and static storage (TA165) Nov 2008 TBC
TA133 Asthma (uncontrolled) - omalizumab (TA133) (replaced by TA278) Nov 2007 TBC
TA83 Hernia - laparoscopic surgery (review) (TA83) Sep 2004 TBC
TA135 Mesothelioma - pemetrexed disodium (TA135) Jan 2008 TBC
TA130 Rheumatoid arthritis - adalimumab, etanercept and infliximab (TA130) Oct 2007 Sep 2010
TA186 Rheumatoid arthritis - certolizumab pegol (TA186) Feb 2010 Sep 2010
TA111 Alzheimer's disease - donepezil, galantamine, rivastigmine (review) and memantine (replaced by TA217) (TA111) (withdrawn) Sep 2007 TBC
TA143 Ankylosing spondylitis - adalimumab, etanercept and infliximab (TA143) May 2008 TBC
TA201 Asthma (in children) - omalizumab (TA201) (replaced by TA278) Oct 2010 Oct 2010
TA174 Leukaemia (chronic lymphocytic, first line) - rituximab (TA174) Jul 2009 TBC
TA193 Leukaemia (chronic lymphocytic, relapsed) - rituximab (TA193) Jul 2010 TBC

This page was last updated: 16 April 2014

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.